ceramides as a new biomarker for cardiovascular risk prediction
Published 2 years ago • 2K plays • Length 11:51Download video MP4
Download video MP3
Similar videos
-
9:11
technology series/medical-cv risk assessment with ceramides
-
15:54
cardiovascular biomarkers of atherosclerotic risk
-
1:30
plasma ceramides: advantages over other biomarker tests that predict risk
-
5:04
plasma ceramides [a test in focus]
-
19:57
cardiovascular laboratory: biomarkers, testing, & clinical implications
-
17:49
ultrasound: incorporate into your critical care assessment
-
11:39
reducing cardiovascular risk in minorities
-
13:39
the role of genetic testing in cardiovascular disease.
-
10:30
biological age and other ai tools in preventive cardiology
-
19:00
cardiovascular disease – there are established biomarkers and new ones | biovendor #22
-
18:28
fostering innovation in cardiology & partnerships between engineers and academics
-
12:11
lipoprotein a: a cardiovascular risk factor commonly ignored
-
17:40
novel biomarkers of cardiovascular risk: an unbiased proteomic approach | peter ganz
-
7:38
ai-ekg screening predicted long-term survival after heart surgery, could be tool for assessing risks
-
1:02:48
ceramides: the unmasked drivers of vlcadd-induced heart failure
-
12:23
covid-19 in cardio oncology
-
10:43
pregnancy-related and other women specific cardiovascular risk factors
-
11:23
high‐throughput screening of new lipid markers for coronary artery disease
-
9:16
the future of cardiac rehabilitation